
Wednesday, August 09, 2017 11:36:15 AM
So, if the AVXL share price was being manipulated artificially low, how would we know?

Liked By
Spread the love. Be the first to like this post!
Recent AVXL News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 05/24/2023 08:44:14 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 05/09/2023 08:32:49 PM
- Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results • GlobeNewswire Inc. • 05/09/2023 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2023 Second Quarter Financial Results on Tuesday, May 9, 2023 • GlobeNewswire Inc. • 05/02/2023 11:30:00 AM
- Anavex Life Sciences Announces Issuance of New U.S. Patent Expanding ANAVEX®2-73 (blarcamesine) Intellectual Property Portfolio for the Treatment of Hypertension • GlobeNewswire Inc. • 05/01/2023 11:30:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 04/25/2023 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 04/14/2023 10:08:18 AM
- Anavex Life Sciences to Present at the 22nd Annual Needham Virtual Healthcare Conference 2023 • GlobeNewswire Inc. • 04/10/2023 11:00:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/04/2023 09:32:52 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/04/2023 09:32:09 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/04/2023 09:31:56 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/04/2023 09:31:41 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/04/2023 09:31:30 PM
- ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48-Week Phase 2 Extension Study in Patients with Parkinson’s Disease Dementia • GlobeNewswire Inc. • 03/30/2023 11:00:00 AM
- Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands • InvestorsHub NewsWire • 03/13/2023 11:35:55 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 10:02:21 AM
- Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as Vice President Head of Biostatistics • GlobeNewswire Inc. • 03/09/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:11:12 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 03:26:43 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/07/2023 10:21:29 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 02/07/2023 10:17:10 PM
- Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results • GlobeNewswire Inc. • 02/07/2023 12:00:00 PM
- Anavex Life Sciences Announces Exceeding of Enrollment Target for the ANAVEX®2-73 (blarcamesine) EXCELLENCE Phase 2/3 Rett Syndrome Clinical Trial • GlobeNewswire Inc. • 02/02/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 01/31/2023 06:59:54 PM
- Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on Tuesday February 7, 2023 • GlobeNewswire Inc. • 01/31/2023 12:00:00 PM
CGrowth Capital Consolidates Lithium Tenement Portfolio in Tanzania Amid Renewed Mining Confidence • CGRA • May 25, 2023 11:05 AM
Interactive Strength Inc. d/b/a FORME Launches European Expansion Plan by Focusing on Strategic Partnership with SIGNA Sports United • TRNR • May 24, 2023 10:14 AM
Nextech3D.ai Game-Changing Generative-AI CAD 3D Design Studio Toggle3D.ai Primed For $7 Million June IPO • NTAR • May 24, 2023 10:00 AM
Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • KAYS • May 24, 2023 9:48 AM
ILUS Confirms Its First Quarter of 2023 Results • ILUS • May 23, 2023 9:34 AM
SKYX Set to Join Russell 2000® and Russell 3000® Indexes • SKYX • May 23, 2023 8:56 AM